Ozempic, Wegovy, Mounjaro, and Zepbound are all FDA-approved weight management solutions, but they each have unique characteristics and mechanisms of action. Ozempic, also known as Semaglutide, is an injectable medication that helps manage blood sugar levels and weight in people with type 2 diabetes. It mimics the action of the hormone GLP-1 to suppress appetite and slow digestion. Wegovy, a higher dose formulation of Semaglutide, is primarily used for weight management in individuals battling obesity or being overweight with at least one weight-related condition. On the other hand, Mounjaro is a newer entrant in the market, and studies suggest its effectiveness in weight reduction. Zepbound also operates by mimicking a hormone that regulates appetite, helping control feelings of hunger and satiety. It's crucial to understand these differences to choose the treatment option best suited to individual health needs and lifestyle preferences.